$0.418
-0.0019[-0.45%]
At close: Apr 25
$0.418
0[0.00%]
After Hours: 7:17PM EDT
Redhill Biopharma
(NASDAQ:RDHL)Redhill Biopharma Stock (NASDAQ:RDHL), Analyst Ratings, Price Targets, Predictions
Redhill Biopharma Ltd has a consensus price target of $19.67, established from looking at the 4 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., Cantor Fitzgerald, and WBB Securities on September 15, 2021, August 31, 2021, and May 28, 2021. With an average price target of $19.67 between HC Wainwright & Co., Cantor Fitzgerald, and WBB Securities, there's an implied 4604.94% upside for Redhill Biopharma Ltd from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Cantor Fitzgerald
WBB Securities
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Redhill Biopharma
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 09/15/2021 | RDHL | Buy Now | Redhill Biopharma | $0.42 | 4923.92% | HC Wainwright & Co. | Raghuram Selvaraju | — | Maintains | Buy | Get Alert |
| 08/31/2021 | RDHL | Buy Now | Redhill Biopharma | $0.42 | 5163.16% | Cantor Fitzgerald | Brandon Folkes | — | Initiates | → Overweight | Get Alert |
| 05/28/2021 | RDHL | Buy Now | Redhill Biopharma | $0.42 | 3727.75% | WBB Securities | Steve Brozak | — | Downgrade | Strong Buy → Buy | Get Alert |
| 05/18/2021 | RDHL | Buy Now | Redhill Biopharma | $0.42 | 5402.39% | HC Wainwright & Co. | Raghuram Selvaraju | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Redhill Biopharma (RDHL)?
The latest price target for Redhill Biopharma (NASDAQ: RDHL) was reported by HC Wainwright & Co. on September 15, 2021. The analyst firm set a price target for $21.00 expecting RDHL to rise to within 12 months (a possible 4923.92% upside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Redhill Biopharma (RDHL)?
The latest analyst rating for Redhill Biopharma (NASDAQ: RDHL) was provided by HC Wainwright & Co., and Redhill Biopharma maintained their buy rating.
When was the last upgrade for Redhill Biopharma (RDHL)?
There is no last upgrade for Redhill Biopharma.
When was the last downgrade for Redhill Biopharma (RDHL)?
The last downgrade for Redhill Biopharma Ltd happened on May 28, 2021 when WBB Securities changed their price target from $17 to $16 for Redhill Biopharma Ltd.
When is the next analyst rating going to be posted or updated for Redhill Biopharma (RDHL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Redhill Biopharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Redhill Biopharma was filed on September 15, 2021 so you should expect the next rating to be made available sometime around September 15, 2022.
Is the Analyst Rating Redhill Biopharma (RDHL) correct?
While ratings are subjective and will change, the latest Redhill Biopharma (RDHL) rating was a maintained with a price target of $23.00 to $21.00. The current price Redhill Biopharma (RDHL) is trading at is $0.42, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.